MENU

Click here to

×

Are you sure ?

Yes, do it No, cancel

DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # | show all

Keywords: Radiobiology
MO-GH-SAN2-8Modeling the Radiation Dose to Circulating Lymphocytes for Different Radiotherapy Modalities and Delivery Parameters
A Hammi*, C Grassberger , H Shih , J Loeffler , H Paganetti , Massachusetts General Hospital, Boston, MA
MO-J430-CAMPUS-F3-1Radiobiological Modeling of the Temporal Behavior of PSA for Low-Risk Prostate Cancer Patients Treated with Moderately Hypo-Fractionated IMRT Alone
R Pino1*, J Grandinetti2 , E Rodriguez1 , W Mai3 , EB Butler1 , BS Teh1 , (1) Houston Methodist Hospital, Houston, TX, (2) UT Southwestern, Dallas, TX, (3) Baylor College of Medicine, Houston, TX
MO-K-301-7TOPAS-NBio: A Monte Carlo Simulation Toolkit for Nanometer-Scale Radiobiology
J Schuemann1*, A McNamara1 , J Ramos-Mendez2 , J Perl3 , K Held1 , H Paganetti1 , S Incerti4 , B Faddegon2 , (1) Massachusetts General Hospital & Harvard Medical School, Boston, MA, (2) University of California San Francisco, San Francisco, CA, (3) Stanford Linear Accelerator Center, Menlo Park, CA, (4) CENBG, CNRS, Bordeaux, France
PO-GePV-T-55NTCP Modeling and Dose-Volume Correlations of Patient Reported Xerostomia 1 Month After Whole-Brain Radiation Therapy
P Mavroidis1*, K Pearlstein2 , D Moon3 , N Sheets4 , M Kasibhatla5 , C Shen6 , N Papanikolaou7 , T Zagar8 , L Marks9 , B Chera10 , S Das11 , K Wang12 , (1) Univ North Carolina, Chapel Hill, NC, (2) UNC at Chapel Hill, Morrisville, NC, (3) UNC at Chapel Hill, Morrisville, NC, (4) UNC Health Care, Chapel Hill, NC, (5) UNC at Chapel Hill, Morrisville, NC, (6) UNC at Chapel Hill, Morrisville, NC, (7) University of Texas HSC SA, San Antonio, TX, (8) UNC at Chapel Hill, Morrisville, NC, (9) University of North Carolina, Chapel Hill, NC, (10) UNC at Chapel Hill, Morrisville, NC, (11) Univ North Carolina, Chapel Hill, NC, (12) UNC at Chapel Hill, Morrisville, NC
PO-GePV-T-57NTCP Modeling and Dose-Volume Correlations of Patient Reported Xerostomia 12 Months After De-Intensified Chemoradiotherapy for HPV Associated Oropharyngeal Cancer
P Mavroidis1*, D Fried2 , A Kubli3 , J Weng4 , R Amdur5 , W Mendenhall6 , N Sheets7 , S Stathakis8 , R Green9 , L Marks10 , S Das11 , B Chera12 , (1) Univ North Carolina, Chapel Hill, NC, (2) UNC Health Care, Chapel Hill, NC, (3) Thomas Jefferson University Hospital, Philadelphia, PA, (4) Duke University, Durham, NC, (5) University of Florida Hospitals, Gainesville, FL, (6) University of Florida, Gainesville, FL, (7) UNC Health Care, Chapel Hill, NC, (8) University Of Texas Health, San Antonio, TX, (9) UNC at Chapel Hill, Morrisville, NC, (10) University of North Carolina, Chapel Hill, NC, (11) Univ North Carolina, Chapel Hill, NC, (12) UNC at Chapel Hill, Morrisville, NC
PO-GePV-T-387Comprehensive and Efficient Quality Assurance Program for Image-Guided Small Animal Irradiation Systems
S Kampfer*, M Duda , J J Wilkens , Klinikum rechts der Isar, Technical University of Munich, Munich, Bayern
PO-GePV-T-393Experimental Platform for Ultra-High-Dose-Rate FLASH Proton Therapy
J Eley1,2*, E Abel3, A Zodda2, A Katsis3, A Marshall3, S Girdhani3, R Parry3, Z Vujaskovic2, I Jackson2, (1) Vanderbilt University School of Medicine, Nashville, TN, (2) University of Maryland School of Medicine, Baltimore, MD, (3) Varian Medical Systems, Palo Alto, CA
PO-GePV-T-396Can Radiation Therapy Enhanced by Cherenkov Photo-Activation (RECA) Elicit a Long-Term Anti-Tumor Effect?
S Yoon*, A Rickard , J Adamson , G Palmer , M Oldham , Duke University Medical Center, Durham, NC
PO-GePV-T-397Minimal Difference Between Fractionated and Single-Fraction Exposure in a Murine Model of Radiation Necrosis
A Boria*, C Perez-Torres, Purdue University, West Lafayette, IN
SU-E-302-5Oxygen Enhancement Ratio for Various Charged Ion Types: Is There a Better Qualifier Than the Linear Energy Transfer?
HHF Choi*, SH Yoo , KY Cheung , SK Yu , Hong Kong Sanatorium & Hospital, Hong Kong
SU-F-SAN1-8New Hybrid 3D Analytical Linear Energy Transfer Calculation Algorithm Based On the Pre-Calculated Data From Monte Carlo Simulations
W Deng*, X Ding , J Younkin , S Schild , J Shen , M Bues , W Liu , Mayo Clinic Arizona, Phoenix, AZ
SU-I300-GePD-F7-2Robust Plan Ranking Using the Equivalent Uniform Dose (EUD) and Equivalent Dose in 2 Gy (EQD2) Fraction Concepts
A Alexandrian*, R Stewart , University of Washington, Seattle, WA
SU-I400-GePD-F4-3Targeting Boron Nanoparticles to the Folate Receptor in Breast Cancer Cells for Hypoxia Imaging
L Chan1*, A Rickard2 , M Zhuang3 , C Fraser3, G Palmer2 , (1) Duke Kunshan University, Suzhou, Jiangsu, (2) Duke University, Durham, NC, (3) University of Virginia, Charlottesville, VA
SU-J400-CAMPUS-F3-1Commissioning and Quality Assurance of An Image-Guided Small Animal Proton/Photon Radiation Research Platform for Radiobiological Studies
M Kim*, P Irmen , K Shoniyozov , I Verginadis , K Cengel , C Koumenis , J Metz , L Dong , E Diffenderfer , University of Pennsylvania, Philadelphia, PA
TH-A-SAN2-9Mid-Treatment Gd-EOB-DTPA-Enhanced MRI and Interleukin 6 Cytokine as Biomarkers of Radiation-Induced Liver Toxicity in Metastatic Liver Patients
A Ajdari1*, Y Xie1 , C Richter2 , T Hong1 , T Bortfeld1 , (1) Massachusetts General Hospital, Boston, MA, (2) OncoRay, Dresden, Germany
TH-BC-SAN1-0Rationale and Evidence for SBRT
V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY
TH-BC-SAN1-1Introduction
V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY
TH-BC-SAN1-2Radiation Therapy Dose Response Modeling and Optimization of Fractionation Schedules with Cancer Stem Cells
V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY
TH-BC-SAN1-3Role of Vascular Damage and Tumor Microenvironment in the Response of Tumors to SBRT and SRS
V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY
TH-BC-SAN1-4Biological Dose Escalation and Outcomes Modeling in the Era of Stereotactic Radiotherapy
V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY
TH-BC-SAN1-5Immunomodulatory Effects of Stereotactic Body Radiation Therapy (SBRT): Preclinical Insights and Clinical Opportunities
V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY
TH-BC-SAN1-6Q&A
V Yu1*, C Song2*, D Carlson3*, A Marciscano4*, (1) UCLA School of Medicine, Los Angeles, CA, (2) University of Minnesota Medical School, Minneapolis, MN, (3) University of Pennsylvania, Philadelphia, PA, (4) Memorial Sloan Kettering Cancer Center, New York, NY
TU-C930-GePD-F7-5Incorporating Tumor Size-Adjusted BED Model Into Eclipse TPS: Prospectively Predicting Local Control Rates of Lung SBRT Patients
Z Pearson*, E Johnson , J Molloy , R McGarry , M Randall , D Pokhrel , Univ Kentucky Medical Ctr, Lexington, KY
TU-E-SAN1-2Radiation Related Lymphopenia for the Treatment of Pancreatic Cancer: Measurement Derived Data for the Development of a Robust Simulation
J Sanders1 , T Jones1 , D Liyanage2 , M Conaway1 , M Peach1 , E Janowski1 , K Wijesooriya1*, (1) University of Virginia, Charlottesville, VA,(2) Albemarle High School, Charlottesville, VA
TU-F115-GePD-F4-4Report of Radiobiological Doses for the Treatment of Ocular Malignancies with Brachytherapy
Z Richards*, B Firestone , C Henson , S Ahmad , T Herman , T De La Fuente Herman , University of Oklahoma Health Sciences Center, Oklahoma City, OK
WE-C1030-GePD-F3-1Quantification of DNA Damage After An Ionizing Irradiation Session
K Chatzipapas1, P Papadimitroulas2 , N Papanikolaou3 , N Kirby3*, G C Kagadis1 , (1) University of Patras, Rion, Greece, (2) BIOEMTECH,Athens, Greece, (3) University of Texas HSC SA, San Antonio, TX, USA
WE-C1030-GePD-F3-3Minimum Required Dose Rate for FLASH RT: A Dimensional Analysis
S Zhou*, D Zheng , S Wang , Q Fan , L Yu , A Besemer , C Zhou , C Enke , University of Nebraska Medical Center, Omaha, NE
WE-C1030-GePD-F3-4Use of Mathematical Model for Elucidation of Molecular Mechanisms of Tumor Necrosis Factor Cytokine Storm in Lung Cancer Patients
J Joo1*, D Ray2 , R Ten Haken3 , T Lawrence4 , I El Naqa5 , (1) University of Michigan Medical Center, Ann Arbor, MI, (2) University of Michigan Radiation Oncology Department, Ann Arbor, ,(3) University of Michigan, Ann Arbor, MI, (4) University of Michigan, Ann Arbor, ,(5) University of Michigan, Ann Arbor, MI
WE-FG-301-3Comparison of Seamless Radiation and Microbeam Radiation in Immunotherapy Enhancement
J Rivera1,2*, K Laemont3 , A Tovmasyan4 , S Stryker3 , G Palmer3 , S Chang2 , (1) UNC-Chapel Hill & NC State University, Chapel Hill, NC, (2) UNC-Chapel Hill School of Medicine, Chapel Hill, NC, (3) Duke University School of Medicine, Durham, NC, (4) Duke University Medical Center, Durham, NC
WE-FG-301-8Parameterization of Percolation Cluster Models to Assess the Radiation Induced Complication of the Parotid Gland in Head and Neck Radiotherapy
M Chao1*, J Wei2 , Y Lo1 , J Penagaricano3 , (1) The Mount Sinai Medical Center, New York, NY, (2) City College of New York, New York, NY, (3) University of Arkansas for Medical Sciences, Little Rock, AR
WE-J-304-8Initial Benchmarking of a Monte Carlo-Based Microdosimetry Platform for the Analysis of Targeted Radionuclide Therapy Agents In-Vitro
D Adam*, N Schweitzer , S Hoffman , B Thomadsen , B Bednarz , University of Wisconsin, Madison, WI